Cargando…
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated i...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052938/ https://www.ncbi.nlm.nih.gov/pubmed/32127956 http://dx.doi.org/10.7150/jca.38399 |
_version_ | 1783502949274615808 |
---|---|
author | Saeki, Kiyoshi Onishi, Hideya Koga, Satoko Ichimiya, Shu Nakayama, Kazunori Oyama, Yasuhiro Kawamoto, Makoto Sakihama, Kukiko Yamamoto, Takeo Matsuda, Ryota Miyasaka, Yoshihiro Nakamura, Masafumi Oda, Yoshinao |
author_facet | Saeki, Kiyoshi Onishi, Hideya Koga, Satoko Ichimiya, Shu Nakayama, Kazunori Oyama, Yasuhiro Kawamoto, Makoto Sakihama, Kukiko Yamamoto, Takeo Matsuda, Ryota Miyasaka, Yoshihiro Nakamura, Masafumi Oda, Yoshinao |
author_sort | Saeki, Kiyoshi |
collection | PubMed |
description | Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated in PDAC cell lines under hypoxia compared to normoxia, and identified human family with sequence similarity 115, member C (FAM115C) as a candidate gene for further study. Our data showed that FAM115C was overexpressed in PDAC cell lines under hypoxia, and FAM115C inhibition promoted PDAC cell migration and invasion in vitro. FAM115C inhibition did not affect tumor cell proliferation in PDAC. Immunohistochemically, FAM115C expression was observed ubiquitously in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) and PDAC tissue, and it was located mainly in the nucleus but also in the cytoplasm of cells. In qPCR analysis, high expression of FAM115C was correlated with better prognosis in patients with PDAC. Our findings suggest that FAM115C could be a novel tumor suppressor associated with prolonged survival in patients with PDAC. |
format | Online Article Text |
id | pubmed-7052938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-70529382020-03-03 FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients Saeki, Kiyoshi Onishi, Hideya Koga, Satoko Ichimiya, Shu Nakayama, Kazunori Oyama, Yasuhiro Kawamoto, Makoto Sakihama, Kukiko Yamamoto, Takeo Matsuda, Ryota Miyasaka, Yoshihiro Nakamura, Masafumi Oda, Yoshinao J Cancer Research Paper Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated in PDAC cell lines under hypoxia compared to normoxia, and identified human family with sequence similarity 115, member C (FAM115C) as a candidate gene for further study. Our data showed that FAM115C was overexpressed in PDAC cell lines under hypoxia, and FAM115C inhibition promoted PDAC cell migration and invasion in vitro. FAM115C inhibition did not affect tumor cell proliferation in PDAC. Immunohistochemically, FAM115C expression was observed ubiquitously in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) and PDAC tissue, and it was located mainly in the nucleus but also in the cytoplasm of cells. In qPCR analysis, high expression of FAM115C was correlated with better prognosis in patients with PDAC. Our findings suggest that FAM115C could be a novel tumor suppressor associated with prolonged survival in patients with PDAC. Ivyspring International Publisher 2020-02-10 /pmc/articles/PMC7052938/ /pubmed/32127956 http://dx.doi.org/10.7150/jca.38399 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Saeki, Kiyoshi Onishi, Hideya Koga, Satoko Ichimiya, Shu Nakayama, Kazunori Oyama, Yasuhiro Kawamoto, Makoto Sakihama, Kukiko Yamamoto, Takeo Matsuda, Ryota Miyasaka, Yoshihiro Nakamura, Masafumi Oda, Yoshinao FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title | FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title_full | FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title_fullStr | FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title_full_unstemmed | FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title_short | FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
title_sort | fam115c could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052938/ https://www.ncbi.nlm.nih.gov/pubmed/32127956 http://dx.doi.org/10.7150/jca.38399 |
work_keys_str_mv | AT saekikiyoshi fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT onishihideya fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT kogasatoko fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT ichimiyashu fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT nakayamakazunori fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT oyamayasuhiro fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT kawamotomakoto fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT sakihamakukiko fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT yamamototakeo fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT matsudaryota fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT miyasakayoshihiro fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT nakamuramasafumi fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients AT odayoshinao fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients |